$1.10
-0.01-0.9%
At close: Aug 7, 5:00 PM EST
$1.16
0.065.45%
After Hours: Aug 7, 9:29 AM EST
Dermata Therapeutics (DRMA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.53 | $-1.54 | $-1.59 | — |
| Actual | $-0.48 | $-1.52 | $-1.65 | $-1.66 |
| Surprise | +9.43% | +1.30% | -3.77% | — |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | — | — |
| Surprise | — | — | — | — |
| Metric | Q2 '26E | Q3 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.55 | $-0.63 |
| Revenue | ||
| Consensus | — | $25000 |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | May 13, 2026 | $-0.48 | $-0.53 | 9.43 % |
| Q4 | Mar 26, 2026 | $-1.52 | $-1.54 | 1.30 % |
| Q3 | Nov 14, 2025 | $-1.65 | $-1.59 | -3.77 % |
| Q3 | Nov 13, 2024 | $-20.40 | $-26.40 | 22.7 % |